A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.
about
Structure prediction and validation of the ERK8 kinase domainBiochemical profiling of histone binding selectivity of the yeast bromodomain familyA unified model of the GABA(A) receptor comprising agonist and benzodiazepine binding sitesStructure and functional analysis of the IGF-II/IGF2R interactionA phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation.Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniquesStructural conservation of druggable hot spots in protein-protein interfacesThe crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complexStructure of the fungal beta-glucan-binding immune receptor dectin-1: implications for functionHuman Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the FutureDrug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening MethodologiesA Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System TargetsThree-dimensional compound comparison methods and their application in drug discoveryA brief history of macromolecular crystallography, illustrated by a family tree and its Nobel fruitsComputational methods in drug discoveryExperimental and computational mapping of the binding surface of a crystalline proteinStructural basis for pterin antagonism in nitric-oxide synthase. Development of novel 4-oxo-pteridine antagonists of (6R)-5,6,7,8-tetrahydrobiopterinStructure of a functional IGF2R fragment determined from the anomalous scattering of sulfur.Structure of tagatose-1,6-bisphosphate aldolase. Insight into chiral discrimination, mechanism, and specificity of class II aldolasesJararhagin-derived RKKH peptides induce structural changes in alpha1I domain of human integrin alpha1beta1Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase InhibitorsMolecular Basis of Kainate Receptor Modulation by SodiumIodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis InhibitorsDesign of O -Acetylserine Sulfhydrylase Inhibitors by Mimicking NatureSulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacyExperimental and computational active site mapping as a starting point to fragment-based lead discoveryDiscovery of 1,2,4-Triazine Derivatives as Adenosine A 2A Antagonists using Structure Based Drug DesignBiophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug DesignMore-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding moleculesEsterase LpEst1 from Lactobacillus plantarum: a novel and atypical member of the αβ hydrolase superfamily of enzymesNF023 binding to XIAP-BIR1: searching drugs for regulation of the NF-κB pathwayEnzyme crystal structure in a neat organic solventBatimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.Interdomain binding of NADPH in p-hydroxybenzoate hydroxylase as suggested by kinetic, crystallographic and modeling studies of histidine 162 and arginine 269 variantsGeomfinder: a multi-feature identifier of similar three-dimensional protein patterns: a ligand-independent approachOptimal assignment methods for ligand-based virtual screeningVirtual Screening Approaches towards the Discovery of Toll-Like Receptor ModulatorsStructural differences of matrix metalloproteinases. Homology modeling and energy minimization of enzyme-substrate complexesSolution structure and p43 binding of the p38 leucine zipper motif: coiled-coil interactions mediate the association between p38 and p43QSAR modeling: where have you been? Where are you going to?
P2860
Q21090822-32C29A65-EA31-4FEB-BF06-512577EABAE9Q21142665-DD778221-67EB-4625-B8A4-051D56C2F5E5Q21559651-795FE0F6-124B-4C7E-BDFF-BBE937E6CFF6Q24301792-FE8566E0-66C4-4C17-A3A7-C817233259F5Q24534951-00DAEFF3-16B0-4694-979C-3DB72599B67BQ24562739-8D6C3DEF-21BF-4E34-AC62-EB30F0A4D07AQ24614979-AC1E4E6C-40E8-4951-84FF-F626C0BC3676Q24644910-3FFFFCA0-2BE2-49DD-971C-BEC5C875402DQ24648836-F98E6D57-8C52-43EA-B174-2B20CD7C9B88Q26740107-735810E6-FF4B-4266-88E2-D12D628BF928Q26745421-33148C07-1E3C-47E4-91AA-10EBD35E3A73Q26781471-F5A9BC16-A492-4639-B199-F2F5BD107928Q26801796-7E63CF8F-4D07-479B-9909-EEF32554B8F3Q26823889-A9004DA2-2B1F-4B0F-8906-89F7CCB39C03Q26997089-11047F69-BFD0-4BE0-A8CF-1E8813FC51FAQ27631035-4745ECF7-8CE0-4D19-B4A8-210A4DAB627DQ27635239-63017DF0-D0BD-41C3-AF81-907C41F45EE6Q27638084-0266FB3D-9F34-4B61-9899-456F52811365Q27638818-FBA82AB6-9B2F-4E8B-9BBF-04C256FDD320Q27642739-F9FBC59E-8AB1-4DC7-9C13-756BDE5FCD9BQ27649995-1C572578-6C51-4DFC-85AD-618172AA1655Q27650810-8B80088D-8F79-4CB7-8277-5BFCFA4D1624Q27653350-CB826E7C-D6FB-4103-9287-B8EBE869A2BDQ27658287-9EF1C6CC-069A-4CC7-A744-AC2810C80B58Q27666968-73390687-6E7F-4A5A-BCEC-3B3790032500Q27676521-E1B52C7A-C0CD-4C19-B944-41D699E5B190Q27676559-595D91CB-F894-4A8D-AB74-46E5370F9935Q27676919-F71B2285-62CF-4912-AF6B-29708C4B5683Q27681644-CDBC0D93-497C-47FB-9776-10DDE242FF70Q27682450-FA17B0A8-1F4A-47C8-9AB3-5B39351E6B5EQ27697656-37A63AE0-6743-4910-909A-E35A04DA5AFDQ27732014-C716DDD7-6608-41AE-A2A0-49DFD41997C6Q27732644-F99278D5-B551-4696-B9ED-BFBC80C61342Q27764924-75E39AC1-3957-4984-8706-6E48803B4A90Q27902261-9D8AB15A-44AE-4616-BB06-86DA8B278500Q27998698-EC5868DB-2921-4052-AAE3-675D9761E847Q28068082-00AC4A47-2D62-4733-AE05-14B0006BD990Q28144131-C3D39B84-8DD0-480D-910D-D55D091BB90BQ28202264-59967201-4110-4A21-898C-1B0592D16DAAQ28222668-37D3319F-36F6-4093-8760-457E45AC789B
P2860
A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.
description
1985 nî lūn-bûn
@nan
1985 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
A computational procedure for ...... ally important macromolecules.
@ast
A computational procedure for ...... ally important macromolecules.
@en
type
label
A computational procedure for ...... ally important macromolecules.
@ast
A computational procedure for ...... ally important macromolecules.
@en
prefLabel
A computational procedure for ...... ally important macromolecules.
@ast
A computational procedure for ...... ally important macromolecules.
@en
P356
P1476
A computational procedure for ...... ally important macromolecules.
@en
P2093
P J Goodford
P304
P356
10.1021/JM00145A002
P407
P577
1985-07-01T00:00:00Z